Abstract 3336: Preclinical activity of NVL-520 in ROS1-driven cancer models with diverse fusion partners and kinase-domain mutations

Authors: Anupong Tangpeerachaikul, Clare Keddy, Katelyn Nicholson, Monika Davare, Henry E. Pelish

Published: 2022-06-15

DOI: 10.1158/1538-7445.am2022-3336

Source: Full article